News

Scientists at the University of Wisconsin–Madison have developed a cost-effective and environmentally sustainable way to make a popular pain reliever and other valuable products from plants instead of petroleum.

An oral vaccine against recurrent UTIs could reduce the need for antibiotic treatment.

The amyotrophic lateral sclerosis (ALS) drug Relyvrio has been pulled from US and Canadian markets by its maker, Amylyx Pharmaceuticals, after topline trial data showed it worked no better than a placebo.

Northwestern Medicine investigators have developed a method to measure protein expression in an individual neuron, a discovery that will enable scientists to study how this process goes awry in disease.

Imagine switching on a light and being able to understand and control the inner dynamics of a cell. By shining lights of different colors on replicates of cells, researchers altered the interactions between cellular elements.

Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice.

A new UNSW-led international study, published today in Nature Geoscience, assessed the levels of PFAS contamination in surface and ground water around the globe.

Researchers have made a breakthrough into how two chronic respiratory diseases in childhood affect the immune system, paving the way for better treatments.

Bacterial populations can remain stable on factory floors despite cleaning efforts in ready-to-eat food production facilities, reports new research.

Researchers have identified microbiota signatures associated with KRAS mutations in people diagnosed with colorectal cancer. The findings suggest that gut microbes may serve as a kind of non-invasive biomarker for identifying subtypes of CRC.